Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177772 · ClinicalTrials.gov registry record
Group Therapy For Dementia Caregivers At Risk For Complicated Grief
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 80
- Enrollment target
NCT03177772: Completed study, sponsored by University of Utah.
NCT03177772 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177772 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The investigators are adapting Complicated Grief Group Therapy (CGGT) for soon-to-be bereaved dementia caregivers at risk for complicated grief-Pre-Loss Group Therapy (PLGT) to facilitate healthy death preparedness and eventual bereavement. This will be the first known application of proven therapeutic strategies to address complicated grief applied to high-risk dementia caregivers prior to care recipient death to mitigate complicated grief. If proven to be effective in attenuating poor bereavement outcomes, PLGT could be translated into comprehensive caregiver support programs and delivered to active caregivers of living persons with dementia at risk for complicated grief through community-based caregiver support groups.
Primary Outcome
Change in pre-loss grief as measured by Inventory of Complicated Grief-revised (Prigerson, et al., 1995; ICG-r)
Interventions
- BEHAVIORAL Pre-loss group therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2021-08-30 |
What the finished NCT03177772 record still lists
NCT03177772 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pre-loss group therapy is the first listed.
NCT03177772 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03177772 about?
NCT03177772 is a clinical study titled "Group Therapy For Dementia Caregivers At Risk For Complicated Grief". The investigators are adapting Complicated Grief Group Therapy (CGGT) for soon-to-be bereaved dementia caregivers at risk for complicated grief-Pre-Loss Group Therapy (PLGT) to facilitate healthy death preparedness and eventual bereavement. This will be the first known application of proven therapeu...
What is the current status of trial NCT03177772?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2018-03-01. Estimated completion is 2021-08-30.
What interventions are being tested in trial NCT03177772?
The interventions under investigation include: Pre-loss group therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03177772?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI